What changes occur to tigecycline's dose with rifampin co administration?

What dose change is recommended when tigecycline is given with rifampin?

The provided information does not include dosing recommendations, pharmacokinetic findings, or label guidance describing how tigecycline dosing should be adjusted when co-administered with rifampin. Because of that, I can’t state what specific dose reduction (or increase) is recommended or at what timing relative to rifampin.

Why might rifampin change tigecycline dosing?

Rifampin is a strong inducer of drug-metabolizing enzymes and transporters, which can lower blood concentrations of co-administered drugs. With tigecycline, that potential interaction could theoretically reduce tigecycline exposure and efficacy, but the exact clinical dose adjustment (if any) depends on the specific regulatory labeling or interaction studies—none of which are included in the provided material.

What would you need to confirm the exact dose adjustment?

To answer precisely, you’d need one of the following sources:
- Tigecycline prescribing information (labeling) section on drug interactions.
- A published pharmacokinetic study evaluating tigecycline + rifampin.
- A drug-interaction database entry that quotes the dosing change for this specific combination.

If you share the tigecycline product label excerpt or the interaction study details you have, I can extract the exact dose modification and the rationale from that text.